Dietary glycemic index, glycemic load, insulin index, fiber and whole-grain intake in relation to risk of prostate cancer
- 529 Downloads
Insulin may play a role in prostate cancer tumorigenesis. Postprandial blood glucose and insulin responses of foods depend importantly on the carbohydrate quality and quantity, represented by glycemic index (GI), glycemic load (GL), fiber and whole-grain content, but are also influenced by intake of protein and other characteristics. The recently developed insulin index (II) quantifies the postprandial insulin secretion, also taking into account these additional characteristics.
We investigated the association between dietary GI, GL, II, fiber, and whole grains and risk of total prostate cancer (n = 5,112) and subgroups of prostate cancer as defined by stage or grade in 49,934 male participants of the Health Professionals Follow-up Study. Multivariate adjusted hazard ratios (HR) and 95% confidence intervals (95% CI) were estimated using Cox proportional hazards regression.
Dietary GI, GL, II, or fiber was not associated with risk of total or subgroups of prostate cancer. We observed a positive association between dietary intake of whole grains and total prostate cancer (HR highest versus lowest quintile 1.13, 95% CI 1.03–1.24), which was attenuated after restriction to PSA-screened participants (HR 1.03, 95% CI 0.91–1.17).
These results suggest that long-term exposure to a diet with a high insulin response does not affect prostate cancer incidence.
KeywordsGlycemic index Glycemic load Insulin index Fiber Whole grains Prostate cancer
The work in this manuscript was supported by grants CA55075 and CA133891 from the National Cancer Institute, National Institutes of Health. Katharina Nimptsch is recipient of a scholarship within the Postdoc-Programme of the German Academic Exchange Service (DAAD).
- 1.Ferlay J, Bray P, Pisani P, Parkin DM (2004) GLOBOCAN 2002: cancer incidence mortality and prevalence worldwide. IARC Press, LyonGoogle Scholar
- 4.Kaaks R (2004) Nutrition, insulin, IGF-1 metabolism and cancer risk: a summary of epidemiological evidence. Novartis Found Symp 262:247–260 (discussion 60–68)Google Scholar
- 6.Roddam AW, Allen NE, Appleby P, Key TJ, Ferrucci L, Carter HB et al (2008) Insulin-like growth factors, their binding proteins, and prostate cancer risk: analysis of individual patient data from 12 prospective studies. Ann Intern Med 149(7):461–471 (W83–W88)Google Scholar
- 22.USDA National Nutrient Database for Standard Reference (2004) Release 17. Agricultural Research Service, Washington, DCGoogle Scholar
- 29.Allen NE, Key TJ, Appleby PN, Travis RC, Roddam AW, Rinaldi S et al (2007) Serum insulin-like growth factor (IGF)-I and IGF-binding protein-3 concentrations and prostate cancer risk: results from the European Prospective Investigation into Cancer and Nutrition. Cancer Epidemiol Biomarkers Prev 16(6):1121–1127CrossRefPubMedGoogle Scholar
- 30.Nimptsch K, Platz EA, Pollak MN, Kenfield SA, Stampfer MJ, Willett WC et al (2010) Plasma insulin-like growth factor 1 is positively associated with low-grade prostate cancer in the Health Professionals Follow-up Study 1993–2004. Int J CancerGoogle Scholar
- 34.Liu S, Manson JE, Stampfer MJ, Holmes MD, Hu FB, Hankinson SE et al (2001) Dietary glycemic load assessed by food-frequency questionnaire in relation to plasma high-density-lipoprotein cholesterol and fasting plasma triacylglycerols in postmenopausal women. Am J Clin Nutr 73(3):560–566PubMedGoogle Scholar